Sofinnova Partners, a Paris, France-based venture capital firm, closed its sixth fund, Sofinnova Capital VI, raising €260m.
Investors in Sofinnova Capital VI include CDC Entreprises, Industrial & Financial Investments Co., JP Morgan Asset Management, funds advised by Partners Group and Skandia Life Insurance Company.
Sofinnova Capital VI already invested in eight start-ups and spinoffs, in disruptive technologies in healthcare therapeutics, medical devices, green chemistry, in wireless and mobile technologies, all led by experienced entrepreneurs and management.
These deals include
– CoAxia, Inc. (USA),
– MD Start (Switzerland),
– Mydeco (UK) and
– Sagem Wireless (France).